Mitsuru Omori, Senior Manager at Japan Research Institute, Appointed Strategic Advisor at TIME TRAVELER Inc.
TIME TRAVELER Inc., a University of Tokyo startup aiming for longevity, announced the appointment of Mitsuru Omori from the Japan Research Institute as a Strategic Advisor to promote the commercialization of its research.
📋 Article Processing Timeline
- 📰 Published: April 8, 2026 at 00:30
- 🔍 Collected: April 7, 2026 at 16:00
- 🤖 AI Analyzed: April 20, 2026 at 19:58 (315h 58m after Collected)
TIME TRAVELER Inc. (Headquarters: Tokyo, Co-CEOs: Rieko Akiyama, Hironobu Hayashi, hereinafter "the Company"), an R&D startup aiming to realize longevity, is pleased to announce that Mitsuru Omori, Senior Manager at the Japan Research Institute, Limited, has been appointed as a Strategic Advisor.
■ Purpose and Background of Appointment
The Company is an R&D startup aiming to realize longevity based on the research results of the Division of Molecular Information (Project/Emeritus Professor Toru Akiyama) at the Institute for Quantitative Biosciences, The University of Tokyo.
In addition to developing new drugs in the fields of anti-aging and aging-related diseases, we are promoting a "plant/algae-derived exosome business" with the aim of creating next-generation healthcare.
This participation aims to connect the research results we have accumulated so far to "business" rather than just keeping them in "science", and to further solidify our progress toward social implementation. We will enhance the feasibility and expansion of our business to form a new industry in the Longevity market.
Mr. Mitsuru Omori has a proven track record of being involved in growth strategies and new business development for diverse companies at the Japan Research Institute, and we will utilize his expertise to jointly materialize our business and brand strategies.
■ Participation in "XPRIZE Healthspan"
Our company has currently advanced to the semifinals of "XPRIZE Healthspan", one of the world's largest scientific competitions hosted by the XPRIZE Foundation in the United States.
We have asked Mr. Omori to join as a member in this project as well, and together with our efforts anticipating the finals in 2030, we will connect this to concrete value creation toward realizing a healthy, long-living society.
■ Profile of Mr. Mitsuru Omori
■ Purpose and Background of Appointment
The Company is an R&D startup aiming to realize longevity based on the research results of the Division of Molecular Information (Project/Emeritus Professor Toru Akiyama) at the Institute for Quantitative Biosciences, The University of Tokyo.
In addition to developing new drugs in the fields of anti-aging and aging-related diseases, we are promoting a "plant/algae-derived exosome business" with the aim of creating next-generation healthcare.
This participation aims to connect the research results we have accumulated so far to "business" rather than just keeping them in "science", and to further solidify our progress toward social implementation. We will enhance the feasibility and expansion of our business to form a new industry in the Longevity market.
Mr. Mitsuru Omori has a proven track record of being involved in growth strategies and new business development for diverse companies at the Japan Research Institute, and we will utilize his expertise to jointly materialize our business and brand strategies.
■ Participation in "XPRIZE Healthspan"
Our company has currently advanced to the semifinals of "XPRIZE Healthspan", one of the world's largest scientific competitions hosted by the XPRIZE Foundation in the United States.
We have asked Mr. Omori to join as a member in this project as well, and together with our efforts anticipating the finals in 2030, we will connect this to concrete value creation toward realizing a healthy, long-living society.
■ Profile of Mr. Mitsuru Omori